TY - JOUR
AU - Austrian, R.
AB - THE JOURNAL OF INFECTIOUS DISEASES • VOL. 141, NO.1. JANUARY 1980 © 1980 by The University of Chicago. 0022-1899/80/4101-0019$00.75 From the Center for Disease Control The protection afforded by the recently licensed location of the patient. Although the vaccine is (November 1977) pneumococcal vaccine appears currently recommended as efficacious for preven­ to be specific against disease caused by pneu­ tion of bacteremic disease and pneumonia in per­ mococci of the 14 capsular polysaccharide types sons older than two years of age, we wished to included in the vaccine [1]. Eighty-three pneu­ characterize the distribution of serotypes in all mococcal types are known; certain of these types ages and types of pneumococcal disease to deter­ constitute antigenically related groups, indicated mine the serotypes that would be useful for devel­ in the Danish system of nomenclature by a num­ opment of an effective vaccine in these groups. ber for the group and a letter for the type within the group [2]. Isolates Previous studies have determined that 790/0­ 90% of bacteremic pneumococcal disease has been Forty-four hospitals in 26 states (figure 1) volun­ caused by pneumococci of groups represented in teered to collaborate in the study. Forty-one of the current formulation 
TI - Epidemiology of Pneumococcal Serotypes in the United States, 1978–1979
JO - The Journal of Infectious Diseases
DO - 10.1093/infdis/141.1.119
DA - 1980-01-01
UR - https://www.deepdyve.com/lp/oxford-university-press/epidemiology-of-pneumococcal-serotypes-in-the-united-states-1978-1979-G5JSZf6tZ7
SP - 119
EP - 123
VL - 141
IS - 1
DP - DeepDyve
ER -